Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,789 across all filing types
Latest filing 2026-06-16 Director's Dealing
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec SE: Dr. Cord Dohrmann, sell
Director's Dealing Classification · 100% confidence The document is a notification and public disclosure of transactions by a person discharging managerial responsibilities (Dr. Cord Dohrmann) involving the sale of shares in Evotec SE. It includes details such as the nature of the transaction (disposal), transaction date, prices, volumes, and the market place (Xetra). This type of disclosure corresponds exactly to Director's Dealing reports, which cover personal share transactions by company directors and executives (insider trades). Given the content, it clearly fits the 'Director's Dealing' category and does not represent financial statements or broader corporate announcements.
2026-06-16 English
Declaration of Corporate Governance 2025
Governance Information Classification · 95% confidence The document is titled “Declaration on corporate governance for the financial year 2025” and details Evotec’s compliance with the German Corporate Governance Code, the working practices of the Management Board and Supervisory Board, board composition, internal rules and governance practices. It is not an annual report itself but a standalone governance declaration, matching the definition of Governance Information (CGR).
2026-06-12 English
Evotec Reports Results of the Annual General Meeting 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a corporate news release announcing the results of Evotec SE’s 2026 Annual General Meeting, detailing voting outcomes, election and re-election of Supervisory Board members and overall share capital representation. It is not the full AGM materials or annual report itself, but an announcement of voting results. This matches the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2026-06-11 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 95% confidence The document is a formal Voting Rights Announcement under Article 40 of the German Securities Trading Act (WpHG), detailing a threshold crossing in major shareholding by JPMorgan entities in Evotec SE. It lists shareholding percentages pre- and post-threshold, ISIN, instruments, and chain of controlled undertakings. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-06-04 English
Evotec Appoints Rui Wang as Head of Global In Silico and AI
Board/Management Information Classification · 92% confidence The document is a corporate news release announcing the appointment of Rui Wang as Executive Vice President, Head of Global In Silico and AI. It contains no financial results or regulatory filing language, but rather an executive management change announcement. This fits the definition of Board/Management Information.
2026-06-02 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 93% confidence The document is a voting rights announcement under Article 40 of the German Securities Trading Act (WpHG) detailing changes in significant share ownership percentages, thresholds crossed, and instrument holdings. This matches the definition of a Major Shareholding Notification rather than a financial report or general announcement. Therefore, it should be classified as Code MRQ.
2026-06-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.